Further analyses of the relationship of MAPKAPK2 mRNA with the clinical pathological characters of glioma patients showed that MAPKAPK2 mRNA levels correlated with glioma grades, IDH genotype, 1p/19q co-deletion status, and the age of patients (Table 1). This evidence concerns the gene MAPKAPK2 and glioma.